Literature DB >> 25929658

Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder.

Carolina Aguirre-Mardones1, Alex Iranzo, Dolores Vilas, Mónica Serradell, Carles Gaig, Joan Santamaría, Eduardo Tolosa.   

Abstract

Parkinson disease (PD) patients may experience nonmotor symptoms (NMS) before Parkinsonism onset. Patients with idiopathic REM sleep behavior disorder (IRBD) eventually develop PD and may represent premotor PD. We aimed to evaluate the prevalence and perceived timeline of NMS in IRBD through validated scales and questionnaires used in PD research. In 44 IRBD patients and 40 matched controls, overall NMS evaluation was assessed by NMS questionnaire for Parkinson disease, olfaction by University of Pennsylvania Smell Identification Test, dysautonomia by scales for outcomes in Parkinson's disease-autonomic, constipation by Rome III criteria, depression by Hospital Anxiety and Depression Scale, cognitive impairment by Montreal cognitive assessment (MoCA) and hypersomnia by Epworth Sleepiness Scale. Patients were asked to report the perceived time of onset of hyposmia, constipation, and depression. Hyposmia (52.3 vs. 20.0 %, p = 0.002) and constipation (56.8 vs. 20.0 %, p = 0.001) were more frequent in patients than in controls. Patients reported more memory problems and showed a trend toward lower score in MoCA. Depression and hypersomnia were not more frequent in patients. The first symptom perceived was RBD in 38.6 % patients, hyposmia in 15.9 %, constipation in 11.4 %, and depression in 6.8 %. The temporal course of the NMS studied was heterogeneous. The three most common presentations were RBD followed by hyposmia; hyposmia followed by RBD; and hyposmia followed by RBD and constipation occurring at the same time span. IRBD patients frequently exhibit NMS that occur in premotor PD, particularly hyposmia and constipation. In IRBD, the perceived timeline of NMS is highly variable. This variability may suggest that pathological changes occurring in IRBD subjects are also heterogeneous and not restricted to the structures that regulate REM sleep.

Entities:  

Mesh:

Year:  2015        PMID: 25929658     DOI: 10.1007/s00415-015-7742-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  69 in total

Review 1.  Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

2.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.

Authors:  Maria Livia Fantini; Ronald B Postuma; Jacques Montplaisir; Luigi Ferini-Strambi
Journal:  Brain Res Bull       Date:  2006-08-07       Impact factor: 4.077

4.  Odor identification deficits in diffuse lewy body disease.

Authors:  Holly James Westervelt; Robert A Stern; Geoffrey Tremont
Journal:  Cogn Behav Neurol       Date:  2003-06       Impact factor: 1.600

5.  Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies.

Authors:  Tanis J Ferman; Glenn E Smith; Kejal Kantarci; Bradley F Boeve; V Shane Pankratz; Dennis W Dickson; Neill R Graff-Radford; Zbigniew Wszolek; Jay Van Gerpen; Ryan Uitti; Otto Pedraza; Melissa E Murray; Jeremiah Aakre; Joseph Parisi; David S Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

6.  Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder.

Authors:  Alex Iranzo; Mónica Serradell; Isabel Vilaseca; Francesc Valldeoriola; Manel Salamero; Cristina Molina; Joan Santamaria; Eduardo Tolosa
Journal:  Parkinsonism Relat Disord       Date:  2013-03-23       Impact factor: 4.891

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Amélie Pelletier; Jacques Montplaisir
Journal:  Mov Disord       Date:  2013-03-28       Impact factor: 10.338

9.  Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.

Authors:  Alex Iranzo; Eduard Tolosa; Ellen Gelpi; José Luis Molinuevo; Francesc Valldeoriola; Mónica Serradell; Raquel Sanchez-Valle; Isabel Vilaseca; Francisco Lomeña; Dolores Vilas; Albert Lladó; Carles Gaig; Joan Santamaria
Journal:  Lancet Neurol       Date:  2013-04-03       Impact factor: 44.182

10.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  12 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

Review 3.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

4.  Clinical update sleep: year in review 2015-2016.

Authors:  Culadeeban Ratneswaran; Jameel Mushtaq; Joerg Steier
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

5.  Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.

Authors:  Yuanyuan Li; Wenyan Kang; Qiong Yang; Lina Zhang; Linyuan Zhang; Fangyi Dong; Shengdi Chen; Jun Liu
Journal:  Neurology       Date:  2017-03-22       Impact factor: 9.910

Review 6.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

Review 7.  The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system.

Authors:  Shu-Ying Liu; Piu Chan; A Jon Stoessl
Journal:  Transl Neurodegener       Date:  2017-02-20       Impact factor: 8.014

Review 8.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

Review 9.  Animal Model for Prodromal Parkinson's Disease.

Authors:  Tomoyuki Taguchi; Masashi Ikuno; Hodaka Yamakado; Ryosuke Takahashi
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

Review 10.  Gut-Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease.

Authors:  Yin-Xia Chao; Muhammad Yaaseen Gulam; Nicholas Shyh Jenn Chia; Lei Feng; Olaf Rotzschke; Eng-King Tan
Journal:  Front Neurol       Date:  2020-08-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.